Yoshida T - Search Results

1

Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.

Shirasawa M, Yoshida T, Shiraishi K, Goto N, Yagishita S, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yotsukura M, Yoshida Y, Nakagawa K, Naoki K, Tsuchida T, Hamamoto R, Yamamoto N, Motoi N, Kohno T, Watanabe SI, Ohe Y. Shirasawa M, et al. Among authors: yoshida y, yoshida t. Br J Cancer. 2023 Dec;129(12):2003-2013. doi: 10.1038/s41416-023-02427-3. Epub 2023 Sep 20. Br J Cancer. 2023. PMID: 37731022

2

Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease.

Yoshida T, Yoh K, Goto K, Niho S, Umemura S, Ohmatsu H, Ohe Y. Yoshida T, et al. Anticancer Res. 2013 Mar;33(3):1175-9. Anticancer Res. 2013. PMID: 23482799

3

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma.

Yoshida T, Ishii G, Goto K, Yoh K, Niho S, Umemura S, Matsumoto S, Ohmatsu H, Nagai K, Ohe Y, Ochiai A. Yoshida T, et al. J Cancer Res Clin Oncol. 2013 Oct;139(10):1691-700. doi: 10.1007/s00432-013-1495-0. Epub 2013 Aug 22. J Cancer Res Clin Oncol. 2013. PMID: 23974272

4

Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.

Takahashi A, Ishii G, Kinoshita T, Yoshida T, Umemura S, Hishida T, Yoh K, Niho S, Goto K, Ohmatsu H, Ohe Y, Nagai K, Ochiai A. Takahashi A, et al. Among authors: yoshida t. J Cancer Res Clin Oncol. 2013 Nov;139(11):1869-78. doi: 10.1007/s00432-013-1502-5. Epub 2013 Sep 7. J Cancer Res Clin Oncol. 2013. PMID: 24013219

5

Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.

Zenke Y, Ishii G, Ohe Y, Kaseda K, Yoshida T, Matsumoto S, Umemura S, Yoh K, Niho S, Goto K, Ohmatsu H, Kuwata T, Nagai K, Ochiai A. Zenke Y, et al. Among authors: yoshida t. Pathol Int. 2013 Dec;63(12):599-606. doi: 10.1111/pin.12122. Pathol Int. 2013. PMID: 24422956

6

Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study.

Yoshida T, Niho S, Toda M, Goto K, Yoh K, Umemura S, Matsumoto S, Ohmatsu H, Ohe Y. Yoshida T, et al. Jpn J Clin Oncol. 2014 Apr;44(4):346-54. doi: 10.1093/jjco/hyu004. Epub 2014 Feb 5. Jpn J Clin Oncol. 2014. PMID: 24503028

7

Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.

Yoshida T, Ishii G, Goto K, Neri S, Hashimoto H, Yoh K, Niho S, Umemura S, Matsumoto S, Ohmatsu H, Iida S, Niimi A, Nagai K, Ohe Y, Ochiai A. Yoshida T, et al. Clin Cancer Res. 2015 Feb 1;21(3):642-51. doi: 10.1158/1078-0432.CCR-14-0846. Epub 2014 Nov 11. Clin Cancer Res. 2015. PMID: 25388165

8

Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth.

Takahashi A, Ishii G, Neri S, Yoshida T, Hashimoto H, Suzuki S, Umemura S, Matsumoto S, Yoh K, Niho S, Goto K, Ohmatsu H, Nagai K, Gemma A, Ohe Y, Ochiai A. Takahashi A, et al. Among authors: yoshida t. Oncotarget. 2015 Apr 20;6(11):9531-41. doi: 10.18632/oncotarget.3371. Oncotarget. 2015. PMID: 25909164 Free PMC article.

9

RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation.

Yoshida T, Yoh K, Niho S, Umemura S, Matsumoto S, Ohmatsu H, Ohe Y, Goto K. Yoshida T, et al. Lung Cancer. 2015 Dec;90(3):477-83. doi: 10.1016/j.lungcan.2015.09.025. Epub 2015 Oct 9. Lung Cancer. 2015. PMID: 26604031

10

Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure.

Yoshida T, Kuroda H, Oya Y, Shimizu J, Horio Y, Sakao Y, Hida T, Yatabe Y. Yoshida T, et al. Lung Cancer. 2017 Jul;109:89-91. doi: 10.1016/j.lungcan.2017.05.001. Epub 2017 May 3. Lung Cancer. 2017. PMID: 28577956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,961 results

Search Page